Page last updated: 2024-10-29

ketamine and Paraparesis, Tropical Spastic

ketamine has been researched along with Paraparesis, Tropical Spastic in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Paraparesis, Tropical Spastic: A subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by HUMAN T-CELL LEUKEMIA VIRUS I. Clinical manifestations include a slowly progressive spastic weakness of the legs, increased reflexes, Babinski signs, incontinence, and loss of vibratory and position sensation. On pathologic examination inflammatory, demyelination, and necrotic lesions may be found in the spinal cord. (Adams et al., Principles of Neurology, 6th ed, p1239)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kubota, T1
Miyata, A1

Other Studies

1 other study available for ketamine and Paraparesis, Tropical Spastic

ArticleYear
Successful use of ketamine for intractable burning pain of HTLV-1-associated myelopathy.
    Journal of pain and symptom management, 2005, Volume: 30, Issue:5

    Topics: Aged; Analgesics; Female; Humans; Ketamine; Pain, Intractable; Paraparesis, Tropical Spastic

2005